Judges: Spain
Filed Date: 3/30/2006
Status: Precedential
Modified Date: 11/1/2024
Appeals (1) from an order of the Supreme Court (Lebous, J.), entered January 14, 2005 in Broome County, which denied defendant Garabed A. Fattal’s motion to set aside the jury verdict, and (2) from an order of said court, entered January 13, 2005 in Broome County, which granted a motion by defendant Our Lady of Lourdes Memorial Hospital for summary judgment on its claims for indemnification and counsel fees.
In November 2000, plaintiff Josephine Ditingo (hereinafter plaintiff), then age 82, had an annual mammogram and ultrasound of her right breast.
When the removed tissue was examined by staff pathologists and the chief of pathology, it was determined that it contained no cancer and that the breast had been unnecessarily removed. The pathologists also reexamined the specimen from the earlier biopsy of the breast, but they did not find infiltrating duct cell carcinoma, as Fattal had diagnosed and which formed the basis for the unnecessary mastectomy; instead, they found a benign papilloma which, at most, would have required a needle excision of the noncancerous lesion and not the removal of the breast.
Plaintiff and her husband, derivatively, commenced this negligence action in 2002 against, among others, Fattal and Lourdes. At the close of proof at the trial, the action was dismissed against all defendants except Fattal, and the court ruled that Lourdes’ liability was solely vicarious. The jury returned a verdict against Fattal and Lourdes in favor of plaintiffs, awarding plaintiff $145,000 for pain and suffering
First, we address and reject Fattal’s challenge to the jury’s award for plaintiffs past and future pain and suffering as excessive. We are guided by the principle that “[a] jury’s assessment of damages in a personal injury case is entitled to great deference, as is a trial court’s decision on a motion to set aside a verdict, and should not be set aside unless the award ‘deviates materially from what would be reasonable compensation’ ” (Laguesse v Storytown U.S.A., 296 AD2d 798, 801 [2002] [citations omitted], quoting CPLR 5501 [c]; see Valentine v Lopez, 283 AD2d 739, 743 [2001]; Lolik v Big V Supermarkets, 266 AD2d 759, 760 [1999]). In our view, the evidence regarding the needless total and permanent surgical removal of plaintiff’s remaining breast, which was not inflicted with cancer, and consideration of the closest comparable cases, fails to provide any arguable support for the claim that the jury’s pain and suffering award materially deviated from reasonable compensation (see Gonzalez v Jamaica Hosp., 25 AD3d 652, 653 [2006]; Sutch v Yarinsky, 292 AD2d 715, 716-717 [2002]; Lopez v Bautista, 287 AD2d 601, 601 [2001] [$750,000/$250,000 award for past and future pain and suffering for failure to detect cancer, later requiring mastectomy]; Motichka v Cody, 279 AD2d 310, 311 [2001], lv denied 97 NY2d 609 [2002] [reduced $2.25 million to $850,000 where the plaintiff had mastectomy but lumpectomy was viable]; King v Jordan, 265 AD2d 619, 621 [1999] [$500,000/ $300,000 award for past and future pain and suffering—same as Motichka]). The evidence established plaintiffs protracted physical pain associated with the mastectomy surgery and her emotional devastation and anxiety surrounding the diagnosis and ordeal. Plaintiffs feelings of shame and self-consciousness with regard to her disfigurement and her increased difficulty and discomfort with wearing a prosthetic as a consequence of losing her remaining breast were also amply demonstrated. Given plaintiffs’ evidence of the short and long-term physical and emotional consequences of Fattal’s misdiagnosis, we agree with Supreme Court’s conclusion that the damages award was not excessive in any respect, nor did it deviate materially from reasonable compensation (see CPLR 5501 [c]).
Next, we find no merit to Fattal’s challenge to Supreme
Cardona, P.J., Mercure, Carpinello and Kane, JJ., concur. Ordered that the orders are affirmed, with one bill of costs.
Plaintiffs left breast had been removed in 1996 after cancer had been detected.